FDA Warns About Anaphylaxis Risk With MS Drug

(MedPage Today) -- The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer acetate (Copaxone, Glatopa), the agency announced on Wednesday.
The warning indicates that anaphylaxis...